Background: Preeclampsia occurs in 3-5% of
pregnancies and is a major cause (12-20 %) of
maternal mortality in developed countries. It is the
leading cause of preterm birth and intra-uterine
growth restrictions (IUGR).
Objective: The study was designed to determine and
demonstrate the ultra structural changes of
endothelial cells in placenta of women suffering from
hypertensive disease.
Patients & Methods: Placental samples were
obtained from two groups of pregnant women
groups (preeclamptic and normal pregnant women).
The specimens were fixed in 2.5% gluteraldehyde
and preceded for electron microscopic examination.
Results: Placenta of women with preeclampsia has
shown marked degenerative changes in both
endothelial and trophoblastic cells. These changes
were represented by precipitation of fibrin with the
accumulation of platelets in capillary lumen.
Abundance of collagen fibers precipitate in the apical
region of both endothelial cells and trophoblasts, with
thickening of endothelial basement membrane.
Conclusion: All histological changes or lesions
obstruct the continuous conduction from maternal
surface of the trophoblasts through fetal capillary
endothelium causing endothelial dysfunction
Electron Microscopic Study of the Effects of Preeclampsia on the Placental Endothelial Cells Ultra Structures during Pregnancy
Preeclampsia
endothelial cell
ultrastructures.
Publication Date
Sun Jun 05 2016
Journal Name
Baghdad Science Journal
Adiponectin , ?-Cell Dysfunction in Iraqi Women with Gestational Diabetes
"Gestational Diabetes Mellitus (GDM)
Adiponectin
Beta Cell Dysfunction
Insulin
Oral Glucose Tolerance Test (OGTT)
C-Reactive Protein (CRP). "
Gestational diabetes mellitus (GDM) is a complication of gestation that is characterized by impaired glucose tolerance with first recognition during gestation. It develops when ?- cell of pancreas fail to compensate the diminished insulin sensitivity during gestation. This study aims to investigate the relationship between mother adiponectin level and ?- cell dysfunction with development gestational diabetes mellitus (GDM) and other parameters in the last trimester of pregnancy. This study includes (80) subjects ( pregnant women) in the third trimester of pregnancy, (40) healthy pregnant individuals as control group aged between (17 - 42) years and (40) gestational diabetes mellitus patients with aged between (20 - 42) years. The f
... Show More